Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 9,230.00
-10.00 (-0.11%)
Mar 18, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 51.1 billion as of March 18, 2026. Its market cap has decreased by -34.84% in one year.
Market Cap
51.10B
Enterprise Value
27.35B
Revenue
24.56B
Ranking
n/a
PE Ratio
14.89
Stock Price
9,230.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 51.10B, a decrease of -82.23%. That is a compound annual growth rate of -66.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 51.04B | -6.29% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.46T |
| Celltrion | 45.86T |
| ALTEOGEN | 18.96T |
| Sam Chun Dang Pharm. | 18.23T |
| MYUNGMOON Pharm co.,Ltd | 62.24B |
| IVIM Technology | 58.97B |
| HASS Corp. | 52.81B |
| Aprogen Biologics | 52.75B |